Volumetric Muscle Loss (VML) is a specific type of muscle injury characterized by the significant loss of muscle tissue volume, typically resulting from severe trauma, surgical intervention, or other traumatic events. Unlike typical muscle injuries, VML involves the removal or destruction of a substantial amount of muscle mass, impairing the affected muscle's structure and function. In VML, the body's natural regenerative mechanisms struggle to repair the extensive muscle loss, leading to functional deficits and chronic impairment. The condition often occurs in conjunction with damage to blood vessels and nerves within the muscle, further complicating the recovery process. Rehabilitation strategies for VML focus on stimulating muscle regeneration and preventing fibrotic tissue formation. Researchers explore various approaches, including stem cell therapy, tissue engineering, and regenerative medicine, to enhance muscle regeneration and functional recovery in individuals with VML. The long-term consequences of VML can be profound, impacting not only muscle strength and mobility but also contributing to secondary issues such as joint instability and altered biomechanics. Managing VML requires a multidisciplinary approach involving physical therapy, surgical interventions, and innovative regenerative therapies to address the complex challenges associated with significant muscle loss.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy